Identification and characterization of a first-generation inhibitor of claudin-1 in colon cancer progression and metastasis

Cancer statistics, 2022

(2022) Rebecca L. Siegel et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Epigenetic Regulation of Claudin-1 in the Development of Ovarian Cancer Recurrence and Drug Resistance

(2021) Zachary R. Visco et al.   Frontiers in Oncology

MASTL regulates EGFR signaling to impact pancreatic cancer progression

(2021) Iram Fatima et al.   ONCOGENE

Cancer statistics, 2019

(2019) Rebecca L. Siegel et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Panitumumab-based maintenance after oxaliplatin discontinuation in metastatic colorectal cancer: a retrospective analysis of two randomised trials

(2019) Dominik Paul Modest et al.   INTERNATIONAL JOURNAL OF CANCER

Claudin-9 structures reveal mechanism for toxin-induced gut barrier breakdown

(2019) Alex J. Vecchio et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Signaling pathways involved in colorectal cancer progression

(2019) Zahra Koveitypour et al.   Cell and Bioscience

Antibody targeting of claudin-1 as a potential colorectal cancer therapy

(2017) S. Cherradi et al.   JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

Claudin-1 promotes TNF-α-induced epithelial-mesenchymal transition and migration in colorectal adenocarcinoma cells

(2016) Ajaz A. Bhat et al.   EXPERIMENTAL CELL RESEARCH

The expression of Claudin 1 correlates with β-catenin and is a prognostic factor of poor outcome in gastric cancer

(2014) JIE HUANG et al.   INTERNATIONAL JOURNAL OF ONCOLOGY

Claudin-1 regulates intestinal epithelial homeostasis through the modulation of Notch-signalling

(2013) Jillian L Pope et al.   GUT

Claudins and the Modulation of Tight Junction Permeability

(2013) Dorothee Günzel et al.   PHYSIOLOGICAL REVIEWS

Claudin-1 expression confers resistance to anoikis in colon cancer cells in a Src-dependent manner

(2012) Amar B. Singh et al.   CARCINOGENESIS

Long-term Expansion of Epithelial Organoids From Human Colon, Adenoma, Adenocarcinoma, and Barrett's Epithelium

(2011) Toshiro Sato et al.   GASTROENTEROLOGY

2,3-Diaryl-2H-1-benzopyran derivatives interfere with classical and non-classical estrogen receptor signaling pathways, inhibit Akt activation and induce apoptosis in human endometrial cancer cells

(2011) I. Fatima et al.   MOLECULAR AND CELLULAR ENDOCRINOLOGY

Phase 2 study of dasatinib in the treatment of head and neck squamous cell carcinoma

(2010) Heather D. Brooks et al.   CANCER

KRAS, BRAF, PIK3CA, and PTEN mutations: implications for targeted therapies in metastatic colorectal cancer

(2010) Wendy De Roock et al.   LANCET ONCOLOGY

Claudin Family of Proteins and Cancer: An Overview

(2010) Amar B. Singh et al.   Journal of Oncology

Claudin-1 Acts through c-Abl-Protein Kinase Cδ (PKCδ) Signaling and Has a Causal Role in the Acquisition of Invasive Capacity in Human Liver Cells

(2009) Chang-Hwan Yoon et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

The claudins

(2009) Madhu Lal-Nag et al.   GENOME BIOLOGY

Claudin 1 overexpression increases invasion and is associated with aggressive histological features in oral squamous cell carcinoma

(2008) Patricia Pintor dos Reis et al.   CANCER

ERK/BCL-2 Pathway in the Resistance of Pancreatic Cancer to Anoikis

(2008) Joseph M. Galante et al.   JOURNAL OF SURGICAL RESEARCH

Determination of microsome and hepatocyte scaling factors forin vitro/in vivoextrapolation in the rat and dog

(2008) R. Smith et al.   XENOBIOTICA

Is Src the key to understanding metastasis and developing new treatments for colon cancer?

(2008) Jiezhong Chen   Nature clinical practice. Gastroenterology & hepatology

Structure and function of claudins

(2007) Gerd Krause et al.   BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES